Roche Diagnostics and BodyMedia® Create Relationship to Provide Innovative Health Information Solutions

Basel, Switz. - February 25, 2003 - Roche Diagnostics and BodyMedia® Inc. announced today a two-year strategic agreement to develop and market innovative health information solutions around continuous body monitoring. This collaboration agreement will focus on optimizing the BodyMedia wearable body- monitoring device and software in clinical applications, starting with clinical weight, diabetes, and cardiovascular disease management.

Under the terms of the agreement, Roche Diagnostics has exclusive worldwide co-development and distribution rights to BodyMedia's technology in several key clinical areas. Roche can contribute to the relationship with expertise in developing actionable health information for chronic diseases, medical products, and healthcare industry needs. Together with BodyMedia, Roche Diagnostics will start a pilot program in 2003 to test an initial offering in the U.S. market. Once customer acceptance and market potential are proven, Roche will implement a broader strategy to distribute BodyMedia's technology platform, including the SenseWear™ Armband, SenseWear™ Transceiver programmable module, and InnerView™ software applications in the fields of clinical and program weight management, diabetes, and cardiovascular disease.

The SenseWear Armband uses multiple sensors and proprietary algorithms to calculate energy expenditure, activity level, number of steps per day, and sleep efficiency. The Transceiver module can be embedded in numerous clinical devices to enable communication with the SenseWear Armband. Additionally, BodyMedia provides software applications to allow individuals and their care providers to track caloric intake, caloric burn, energy balance, and other key body parameters.

By integrating clinical information, such as blood glucose, blood pressure, and heart rate into the BodyMedia lifestyle information, rich content and patient coaching can be given to the wearer to assist in managing chronic diseases.

"Roche Diagnostics is committed to innovations around actionable health information and e-health. BodyMedia's technology and software are complementary to our current offerings around diabetes and other chronic diseases. We believe that continuous body monitoring is a unique way to combine lifestyle information with clinical disease information from numerous devices to deliver actionable information for both the patient and the professional caregiver." said Heino von Prondzynski, head of Roche Diagnostics and a member of Roche's Corporate Executive Committee.

"Obesity is a growing epidemic in industrialized nations, with a tremendous impact on numerous diseases and healthcare spending. The weight management market in the United States alone is over 40 billion dollars. Approximately two of three Americans are overweight or obese, and over 45% of the population of people with diabetes in the United States are also treated for obesity." he added.

"Roche Diagnostics is a world-class, innovative organization and the leading in-vitro diagnostics company globally, with a strong history of developing and selling groundbreaking medical technologies. We are excited about the opportunity to further develop and accelerate BodyMedia's technology into these clinical market," said Dr. Astro Teller, CEO of BodyMedia, Inc.

About Roche and the Roche Diagnostics Division

Headquartered in Basil, Switzerland, Roche is one of the world's leading research-oriented healthcare groups. The company's two core businesses in pharmaceuticals and diagnostics provide innovative products and services that address prevention, diagnosis and treatment of diseases, thus enhancing people's health and quality of life. The two core businesses employ about 57,000 employees worldwide. Roche's Diagnostics Division, the world leader in in vitro diagnostics with a uniquely broad product portfolio, supplies a wide array of innovative testing products and services to researchers, physicians, patients, hospitals and laboratories worldwide. Roche Diagnostic's North American headquarters are located in Indianapolis, Ind. For further information, please visit our websites, www.roche.com and www.roche-diagnostics.com.

About BodyMedia, Inc.

Headquartered in Pittsburgh, Pennsylvania, BodyMedia makes wearable body monitors and easy-to-use software that collect, store, process, and represent body data such as energy expenditure (calories burned), activity levels, sleep states, and other important physiologic data anytime, anywhere. Their monitors are small, body conforming, and lightweight and can be worn for many days at a time, creating medically accurate physiological records of the wearer. BodyMedia offers these products as well as customized applications for a wide range of market needs including self-care weight management, fitness, lifestyle management, assisted living, and clinical fields of use. For more information about BodyMedia and its innovative solutions, please visit www.bodymedia.com.